Horan Capital Advisors LLC. raised its position in Express Scripts Holding (NASDAQ:ESRX) by 7,734.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 29,929 shares of the company’s stock after purchasing an additional 29,547 shares during the period. Horan Capital Advisors LLC.’s holdings in Express Scripts were worth $2,365,000 as of its most recent filing with the SEC.
Other large investors have also recently modified their holdings of the company. SeaCrest Wealth Management LLC bought a new stake in Express Scripts in the fourth quarter valued at approximately $105,000. Bank of Nova Scotia Trust Co. bought a new stake in Express Scripts in the third quarter valued at approximately $120,000. Monroe Bank & Trust MI increased its stake in Express Scripts by 74.8% in the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after purchasing an additional 970 shares in the last quarter. Harvest Fund Management Co. Ltd bought a new stake in Express Scripts in the fourth quarter valued at approximately $183,000. Finally, Atlas Brown Inc. bought a new stake in Express Scripts in the fourth quarter valued at approximately $212,000. 87.86% of the stock is owned by hedge funds and other institutional investors.
In related news, VP Glen D. Stettin sold 3,448 shares of the stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Christine Houston sold 10,104 shares of the stock in a transaction on Friday, December 15th. The stock was sold at an average price of $70.08, for a total transaction of $708,088.32. Following the transaction, the vice president now owns 87,400 shares of the company’s stock, valued at approximately $6,124,992. The disclosure for this sale can be found here. Insiders have sold 17,001 shares of company stock valued at $1,249,505 in the last 90 days. 0.68% of the stock is currently owned by corporate insiders.
Shares of Express Scripts Holding (ESRX) opened at $73.35 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.61 and a debt-to-equity ratio of 0.86. Express Scripts Holding has a 12-month low of $55.80 and a 12-month high of $83.49. The stock has a market cap of $42,449.65, a price-to-earnings ratio of 10.96, a PEG ratio of 0.83 and a beta of 0.93.
Express Scripts declared that its Board of Directors has approved a stock buyback program on Monday, December 18th that allows the company to buyback 45,000,000 shares. This buyback authorization allows the company to reacquire shares of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s management believes its stock is undervalued.
COPYRIGHT VIOLATION NOTICE: “Express Scripts Holding (ESRX) Holdings Raised by Horan Capital Advisors LLC.” was first reported by Community Financial News and is owned by of Community Financial News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://www.com-unik.info/2018/02/09/express-scripts-holding-esrx-holdings-raised-by-horan-capital-advisors-llc.html.
About Express Scripts
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.